Production of a Recombinant Dengue Virus 2 NS5 Protein and Potential Use as a Vaccine Antigen.

about

Discordant congenital Zika syndrome twins show differential in vitro viral susceptibility of neural progenitor cells.Recent Developments in Recombinant Protein-Based Dengue Vaccines

P2860

Q48042024-F94FAA40-56AE-43C1-B528-1FB230DC69CA Q56960671-334BD0AF-C0A4-4BF5-BE22-697A78177329

P2860

Production of a Recombinant Dengue Virus 2 NS5 Protein and Potential Use as a Vaccine Antigen.

Item

http://www.wikidata.org/entity/Q38871575

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Production of a Recombinant De ...... tial Use as a Vaccine Antigen.

@en

type

Item

label

Production of a Recombinant De ...... tial Use as a Vaccine Antigen.

@en

prefLabel

Production of a Recombinant De ...... tial Use as a Vaccine Antigen.

@en

P1476

Production of a Recombinant De ...... tial Use as a Vaccine Antigen.

@en

P2093

Camila Malta Romano

http://www.w3.org/2001/XMLSchema#string

Denicar Lina Nascimento Fabris

http://www.w3.org/2001/XMLSchema#string

Felipe Scassi Salvador

http://www.w3.org/2001/XMLSchema#string

Lennon Ramos Pereira

http://www.w3.org/2001/XMLSchema#string

Paolo Marinho de Andrade Zanotto

http://www.w3.org/2001/XMLSchema#string

Robert Andreata Santos

http://www.w3.org/2001/XMLSchema#string

Rúbens Prince Dos Santos Alves

http://www.w3.org/2001/XMLSchema#string

P2860

Conservation and variability of dengue virus proteins: implications for vaccine design

Maturation of dengue virus nonstructural protein 4B in monocytes enhances production of dengue hemorrhagic fever-associated chemokines and cytokines

The global distribution and burden of dengue

Structural proteomics of dengue virus

Isolation of three strains of type 1 dengue virus from a local outbreak of the disease in Malaya

Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine.

Crystal Structure of the Dengue Virus RNA-Dependent RNA Polymerase Catalytic Domain at 1.85-Angstrom Resolution

Both Virus and Tumor Necrosis Factor Alpha Are Critical for Endothelium Damage in a Mouse Model of Dengue Virus-Induced Hemorrhage

An Immunogenic and Protective Alphavirus Replicon Particle-Based Dengue Vaccine Overcomes Maternal Antibody Interference in Weanling Mice

Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody

P304

460-469

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/CVI.00081-16

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Luis Carlos de Souza Ferreira

Jaime Henrique Amorim

P577

2016-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27030586

http://www.w3.org/2001/XMLSchema#string

P921

Dengue virus

P932

4895003

http://www.w3.org/2001/XMLSchema#string

Production of a Recombinant Dengue Virus 2 NS5 Protein and Potential Use as a Vaccine Antigen.

about

P2860

P2860

Production of a Recombinant Dengue Virus 2 NS5 Protein and Potential Use as a Vaccine Antigen.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932